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Summary
Background—Bronchopulmonary dysplasia (BPD) results from alveolar simplification and 
abnormal development of alveolar and capillary structure. Survivors of BPD display persistent 
deficits in airflow and membrane and vascular components of alveolar gas diffusion. Despite being 
the defining feature of BPD, various neonatal hyperoxia models of BPD have not routinely 
assessed pulmonary gas diffusion.
Methods—To simulate the most commonly-utilized neonatal hyperoxia models, we exposed 
neonatal mice to room air or ≥90% hyperoxia during key stages of distal lung development: 
through the first 4 (saccular), 7 (early alveolar), or 14 (bulk alveolar) postnatal days, followed by a 
period of recovery in room air until 8 weeks of age when alveolar septation is essentially 
complete. We systematically assessed and correlated the effects of neonatal hyperoxia on the 
degree of alveolar–capillary structural and functional impairment. We hypothesized that the degree 
of alveolar–capillary simplification would correlate strongly with worsening diffusion impairment.
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Results—Neonatal hyperoxia exposure, of any duration, resulted in alveolar simplification and 
impaired pulmonary gas diffusion. Mean Linear Intercept increased in proportion to the length of 
hyperoxia exposure while alveolar and total lung volume increased markedly only with prolonged 
exposure. Surprisingly, despite having a similar effect on alveolar surface area, only prolonged 
hyperoxia for 14 days resulted in reduced pulmonary microvascular volume. Estimates of alveolar 
and capillary structure, in general, correlated poorly with assessment of gas diffusion.
Conclusion—Our results help define the physiological and structural consequences of 
commonly-employed neonatal hyperoxia models of BPD and informtheir clinical utility.
Keywords
bronchopulmonary dysplasia; pulmonary diffusion capacity; lung function; neonatal; hyperoxia
INTRODUCTION
Bronchopulmonary dysplasia (BPD) is the most prevalent long-term consequence of 
extremely preterm birth.1 BPD is strongly associated with adverse neurodevelopmental and 
pulmonary outcomes with respiratory morbidities lasting well beyond childhood.2–4 The 
mechanical ventilation and supplemental oxygen required to support extremely preterm 
infants has been shown in human and animals studies to disrupt normal alveolar 
development leading to enlarged airspaces, reduced pulmonary microvasculature, and a 
diminished surface area for gas exchange.5–9 Despite improvement in clinical respiratory 
symptoms with time, BPD survivors have a reduced diffusing capacity of the lung for carbon 
monoxide (DLCO) with normal alveolar volume (VA) suggesting larger, more simplified 
alveoli.5,10
While animal models of BPD have assessed the structural consequences of neonatal lung 
injury, the functional consequences have not been well described. Various durations and 
degrees of neonatal hyperoxia have been used to effectively inhibit both alveolar and 
capillary development, resulting in reduced alveolar surface area and capillary density, but 
they have not assessed systematically the impact on alveolar–capillary function.11–14 
Because BPD is defined clinically as dependence on supplemental oxygen,15,16 it would be 
beneficial to assess not only the structural, but also the functional consequences resulting 
from commonly-employed neonatal hyperoxia models to inform their physiological 
relevance.
The pulmonary diffusing capacity, a functional measure of the alveolar capillary unit, is 
determined primarily by the alveolar surface area and the alveolar capillary volume.17–19 
When a gas molecule enters the alveolar space, it first diffuses across the alveolar membrane 
(membrane component), then enters the capillary space and reacts with red blood cell 
hemoglobin (vascular component). We and others have utilized a simple method to assess 
pulmonary gas diffusion per alveolar volume in rodents, termed the diffusion factor for 
carbon monoxide (DFCO), which is the relation between the uptake of carbon monoxide 
(CO) and the dilution of neon (Ne) during a single breath hold.20,21 Using a model of 
neonatal hyperoxia exposure for the first 7 postnatal days, we recently demonstrated that, 
despite recovery in room air, there are persistent structural changes induced by hyperoxia, 
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consisting of larger, more simplified airspaces with normal alveolar volume, that are 
accompanied by functional impairment as evidenced by significant reductions in adult 
DFCO.21
The purpose of this study was to relate the structural changes resulting from differing 
durations of hyperoxia exposure commonly utilized in the literature, which correspond to 
lung injury during critical stages of pulmonary development, to functional changes as 
measured by DFCO. We hypothesized that increasing the duration of initial neonatal 
hyperoxia exposure would result in more severe alveolar–capillary simplification, as 
evidenced structurally by reduced alveolar surface area and capillary volume, and 
physiologically by impaired pulmonary diffusion. Given that pulmonary diffusion is 
determined predominately by the surface area of the alveolar membrane and the pulmonary 
capillary volume,19,22 we focused our assessment of lung structure on alveolar surface area 
and estimates of pulmonary microvascular volume. The mean linear intercept (MLI), in the 
context of lung volume, estimates alveolar surface area, and assuming that changes in 
alveolar wall thickness are minimal, the volume fraction of the alveolar wall correlates 
roughly with alveolar complexity. We previously demonstrated that these estimates of 
alveolar–capillary structural development and DFco are correlated.21 Therefore, we 
predicted that the degree of alveolar–capillary simplification, as measured by the 
aforementioned stereological estimates of alveolar surface area and alveolar microvascular 
volume, would correlate strongly with the degree of diffusion impairment.
MATERIALS AND METHODS
Murine Neonatal Hyperoxia Exposure Model of BPD
All procedures were approved by the Institutional Animal Care and Use Committee of the 
Indiana University School of Medicine (protocol 10897) and were previously described.21 
For each individual experimental exposure, two or more litters of wild-type C57BL/6J mice 
<12 hr of age and born <12 hr apart were pooled and separated into two equal groups of up 
to eight mice. Half of the pups were placed in a 30″ × 20″ × 20″ propylene chamber in 
which the oxygen concentration was maintained at ≥90% O2 (BioSpherix, Lacona, NY), and 
the other half were maintained in room air (RA; 21% O2). Nursing dams were rotated 
between groups every 48 hr to prevent oxygen toxicity to the dams. Humidity and carbon 
dioxide levels were maintained within the ambient range of the facility. To determine the 
effect of hyperoxic injury during different stages of lung development, pups were 
continuously exposed to hyperoxia for the first 4, 7, or 14 postnatal (P) days, which 
corresponds to the murine saccular phase (P0-P4), early alveolarization (P7), and bulk 
alveolarization (P14). To simulate the period of clinical recovery typically observed in 
preterm infants through childhood and adolescence, mice were allowed to recover in RA 
until 8 weeks of age when alveolar septation is essentially complete,23 at which time all 
structural and functional analyses were performed.
Assessment of Diffusing Factor for Carbon Monoxide (DFCO)
DFCO was assessed with a 3000 Micro GC bench top gas chromatographer (INFICON, East 
Syracuse, NY) using 0.8 ml of test gas (0.5% Ne; 0.5% CO; 21% O2; balance nitrogen) to 
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inflate the lungs over a 6-second breath hold as previously described.21,24 The 6-second 
breath hold was used to minimize the potential for bradycardia which would potentially 
impact cardiac output. Although rare in our experience, any subject that experienced 
significant bradycardia (>10% of baseline) was excluded from analysis. Mice were 
anesthetized with 50 mg/kg pentobarbital i.p., an 18g, 0.05-inch catheter was placed in the 
mid trachea via tracheostomy and secured with suture, and mice were ventilated with a 
flexiVent (SCIREQ, Montreal, Canada) using 21% O2, tidal volume of 10 ml/kg at a rate of 
150 breaths/min, and positive end expiratory pressure of 3 cm H2O. Alveolar volume was 
estimated by the degree of neon dilution in the 0.8 ml test gas solution, following the 6-
second breath hold, as per the American Thoracic Society/European Respiratory Society 
Task Force 19 using the equation VA=VI (FI,Tr/FA,Tr) where VI is the volume of the inhaled 
test gas and FI,Tr/FA,Tr is the ratio of neon concentration before and after dilution of the test 
gas in the alveolar space. Although the volume of the conducting airways (the anatomical 
dead space) would certainly contribute to neon dilution, for simplicity we disregarded it in 
our calculations as we assumed anatomical dead space amongst all treatment groups was 
similar. Each measurement was separated by a 150 sec period of mechanical ventilation to 
ensure disappearance of carbon monoxide and neon from the previous measurement. After 
measuring the DFCO, a whole blood sample was obtained to determine hemoglobin and 
hematocrit concentration using a Hemavet (Drew Scientific, Waterbury, CT).
Lung Histology and Morphometry
Immediately following functional analyses, the lungs were inflation-fixed, processed, and 
embedded in paraffin exactly as previously described.6 Morphometric analyses were 
performed on 7-μm thick transverse sections from the left lung stained with hematoxylin and 
eosin. Shrinkage effects due to paraffin embedding were assumed to be similar amongst the 
experimental groups, and the use of a reference volume and point-counting were employed 
to minimize its confounding effects. From 4–6 randomly-selected sections representative of 
the entire length of the lung, a minimum of 6–8 random total fields were photographed with 
a 5× objective and 12 total random fields that contained distal airspaces were photographed 
with a 20× objective on a Zeiss Axioshop2Plus microscope (Carl Zeiss Inc., Thornwood, 
NY). Images used for morphometric analysis and microvascular volume determination, 
taken at 20× objective, consisted of fields containing alveolar structures, avoiding large 
vessels, or conducting airways. The STEPanizer stereology tool, version 1.0 was used to 
determine alveolar surface area and calculate MLI as previously described.25,26 Pulmonary 
microvasculature was identified by immunohistochemical staining for the endothelial 
marker, von Willebrand factor (vWF; rabbit polyclonal anti-human vWF; dilution 1:2500;
[A0082]; Dako, Carpinteria, CA), using the Vectastain Elite ABC kit (Vector Laboratories, 
Burlingame, CA) with diaminobenzidine (Vector Laboratories) as previously described,6 and 
alveolar microvascular volume was estimated via the STEPanizer tool.
Statistical Analysis
Statistical analyses were performed using Prism software version 6.04 (GraphPad Inc., San 
Diego, CA). Comparisons between experimental groups (RA vs. hyperoxia) were made with 
one way ANOVA using Tukey’s multiple comparison post-test analysis. All data are 
presented as means±SEM (with n≥9 mice per group) and are representative of at least 2–3 
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independent hyperoxia exposures per time-point. A P-value <0.05 was considered 
statistically significant.
RESULTS
Neonatal Hyperoxia Impairs Alveolar–Capillary Diffusion
Analysis of adult alveolar–capillary function following neonatal hyperoxia demonstrated 
persistently impaired diffusion. Remarkably, impaired diffusion was evident with even the 
shortest duration of oxygen exposure (Fig. 1). Compared to RA controls, DFCO was 
similarly reduced following neonatal hyperoxia exposure from P0-4 to P0-7 (Fig. 1A). 
Animals exposed to neonatal hyperoxia from P0-14 demonstrated a reduction in DFCO that 
was significantly more severe compared to shorter durations of oxygen exposure. As 
calculated by neon dilution, neonatal hyperoxia from P0-4 to P0-7 resulted in similar small 
(~15%) but statistically significant increases in alveolar volume (VA) (Fig. 1B). However, 
VA was significantly increased by ~50% in animals exposed to prolonged (P0-14) hyperoxia 
(Fig. 1B). Hemoglobin values were not significantly different than RA controls following 
any duration of hyperoxia exposure (14.0 ± 0.3 g/dl (RA) vs. 13.2±0.4 g/dl (O2 P0-4) vs. 
14.5±0.4 g/dl (O2 P0-7) vs. 13.6 ± 0.3 g/dl (O2 P0-14); P > 0.05 vs. RA), verifying that 
differences in DFCO did not result from decreases in hemoglobin concentration.
Neonatal Hyperoxia Durably Reduces Alveolar Surface Area
Given the significant reductions we observed in alveolar–capillary diffusion capacity, we 
more closely examined alveolar surface area following neonatal hyperoxia. Representative 
adult lung histology is shown in Figure 2. Compared to mice raised in RA, mice previously 
exposed to hyperoxia from P0-4, P0-7, to P0-14 demonstrated increasing alveolar 
simplification (Fig. 2A–D). Compared to RA controls, mean linear intercept (MLI) of mice 
exposed to hyperoxia showed an almost stepwise increase proportionate to the duration of 
neonatal hyperoxia (Fig. 2E). Unlike estimates of VA, exposure to hyperoxia from either 
P0-4 or P0-7 had no significant effect on lung volume as measured by water displacement 
(Fig. 2F). However, exposure to hyperoxia from P0-14 resulted in a significant 29% increase 
in lung volume compared to RA control mice (Fig. 2F). Estimates of VA by neon dilution 
correlated reasonably well with estimates of lung volume by water displacement (r2 = 0.599, 
P < 0.0001). Consequently, compared to RA controls, the total alveolar surface area was 
similarly and significantly reduced in all hyperoxia-exposed animals (Fig. 2G). Likewise, 
following any exposure to hyperoxia, the volume of the alveolar wall (Vaw) was similarly 
and significantly decreased by at least 20% compared to RA controls (0.062±0.002 ml [RA] 
vs. 0.046±0.002 ml [O2 P0-4] vs. 0.050±0.003 ml [O2 P0-7] vs. 0.046±0.003 ml [O2 P0-14]; 
P < 0.0001 vs. RA) (not shown). Therefore, despite having significantly larger distal 
airspaces compared to animals exposed to shorter durations of hyperoxia, animals exposed 
to neonatal hyperoxia from P0-14 had similar alveolar wall volumes and a relative 
preservation of alveolar surface area owing to the significant increase in lung volume.
Assessment of pulmonary microvascular volume is shown in Figure 3. Although there was a 
downward trend in pulmonary microvascular volume after neonatal hyperoxia exposure 
from P0-4 to P0-7, it was not statistically significant compared to RA. Only hyperoxia 
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exposure from P0-14 resulted in a significantly decreased pulmonary microvascular volume 
when compared to RA controls.
Assessment of alveolar development has largely relied on morphometric and not 
physiological analysis. We therefore, correlated our structural and functional endpoints to 
determine if structure alone can estimate functional diffusion (Fig. 4). None of our 
stereological assessments of alveolar structure were strongly correlated with alveolar 
function. There was a weak but statistically significant correlation between MLI and DFCO 
(r2 = 0.282, P < 0.01) (Fig. 4A), as well as between DFCO and the volume fraction of the 
alveolar septal wall (r2 = 0.224, P < 0.01) (Fig. 4B). Total alveolar surface area correlated 
poorly with DFCO (r2 = 0.084, P > 0.05) (Fig. 4C), and, likewise, there was no significant 
correlation between DFCO and pulmonary microvascular volume (r2 = 0.001, P > 0.05) (Fig. 
4D). Given that DFCO estimates gas diffusion per lung volume, we also assessed the 
correlation between DFCO and stereological estimates of lung structure corrected for lung 
volume. There was a weak but statistically significant correlation between DFCO and 
alveolar surface area per lung volume (r2 = 0.358, P < 0.001) (Fig. 4E). However, there was 
no significant correlation between DFCO and pulmonary microvascular volume per lung 
volume (r2 = 0.036, P > 0.05) (Fig. 4F).
DISCUSSION
The objective of this study was to correlate commonly-employed measures of distal lung 
structural development with alveolar–capillary function following increasing durations of 
neonatal hyperoxia during critical windows of alveolar development. Importantly, we have 
demonstrated that even brief hyperoxic lung injury, limited to postnatal saccular lung 
development, is sufficient to significantly impair development of alveolar surface area and 
reduce functional gas diffusion. Surprisingly, structural estimates of alveolar development 
and assessments of functional diffusion correlated poorly. Our approach lends clinically 
significant functional insight into commonly-employed murine neonatal hyperoxia models 
of BPD, as well as potentially informs pathophysiology of any lung disease that impacts 
alveolar–capillary function.
The defining feature of BPD following extremely preterm birth is prolonged dependence on 
supplemental oxygen.15,16 Despite clinical improvement, children, adolescents, and adults 
recovering from BPD continue to have functional lung impairment with reduced pulmonary 
diffusing capacity.5,10,27–31 Following neonatal hyperoxia exposure, we demonstrated that 
adult mice have a reduced DFCO, signifying a similar impairment in pulmonary gas 
diffusion. Regardless of the duration of hyperoxia, alveolar gas transport was significantly 
inhibited by neonatal hyperoxia exposure. Although chronic exposure (P0-14) resulted in the 
largest decline in DFCO, impaired alveolar–capillary diffusion was nearly as severe with 
brief (P0-4) exposure. The similar reductions in diffusion are likely the result of similar loss 
of alveolar surface area, as evidenced by similar decreases in alveolar surface area and septal 
wall volume regardless of the duration of hyperoxia. Mild alveolar fibrosis observed 
following chronic hyperoxia (not shown) may explain why the efficiency of alveolar–
capillary diffusion in these animals, noted especially after 14 days of hyperoxia, was further 
reduced. Furthermore, we made an assumption that anatomical dead space amongst all 
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exposure groups was similar. However, although anatomical volume was not measured, 
reports have noted abnormal development and function of the conducting airways following 
neonatal hyperoxia.32,33 Therefore, it is possible that increased volume of the anatomical 
dead space could impact our estimates of DFco and alveolar volume and account for some 
of the differences we observed. However, given the relatively large changes in alveolar 
volume (which directly correlated with changes in total lung volume), a significant effect 
due to increased anatomical dead space volume is unlikely. Finally, although we were not 
able to assess for such here, recent evidence suggests that infants with the most severe forms 
of BPD can develop pre-capillary arteriovenous anastomoses, which would further impede 
pulmonary diffusion efficiency.34
Although DFCO was reduced with all durations of neonatal hyperoxia, we were surprised 
that only prolonged hyperoxia (which may not be developmentally relevant to the clinical 
scenario) resulted in reduced pulmonary microvascular volume. Likewise, despite capillary 
volume, by definition, being a major component of total pulmonary diffusion,17 pulmonary 
microvascular volume and DFCO correlated poorly. It has been recently reported that 
extremely preterm infants formerly diagnosed with BPD demonstrated proportional 
reductions in both membrane and vascular components of pulmonary diffusion, consistent 
with autopsy studies demonstrating larger, fewer alveoli with reduced pulmonary capillary 
volume.8,9,28 Likewise, in an animal model of BPD, we formerly demonstrated that 
pulmonary micro-vessels per high-powered field were reduced, which would correlate with a 
reduction in microvascular density per alveolar volume.21 Our current analysis goes one step 
forward and provides a stereological approach to quantitate microvascular volume more 
carefully, which accounts for differences in lung volume that cannot be ascertained by two-
dimensional analysis as is commonly employed. One limitation of our assessment of 
pulmonary capillary volume is the use of von Willebrand staining, which identifies both 
small venuoles and arterioles, and may not be an appropriate surrogate of the pulmonary 
capillary bed.35 Although assessment of capillary structure, via direct visualization of 
capillary structure and/or micro-CT, may have provided a more accurate estimate of 
alveolar–capillary membrane surface area, our objective was to assess commonly-employed 
methods of assessing pulmonary microvasculature, of which von Willebrand staining has 
been reported frequently. Moreover, it is the capillary volume, in combination with the 
membrane surface area, which determines total pulmonary diffusion. Ideally, physiological 
resolution of both components, as has been shown in infants recovering from BPD,28 would 
provide the most accurate estimates of their individual contributions. Additionally, given that 
we previously showed that exposure to neonatal hyperoxia leads to elevations in adult 
cardiac output as a potential compensatory response to reduced alveolar surface area,36,37 it 
is possible that smaller reductions in alveolar microvascular volume with shorter durations 
of neonatal hyperoxia were partially compensated and therefore, were not detected by 
DFCO. Finally, the loss of microvascular volume may help explain why animals exposed to 
prolonged neonatal hyperoxia, despite having similar reductions in alveolar surface area 
compared to shorter durations of neonatal hyperoxia, demonstrated significantly more 
impairment in gas diffusion.
Many prior studies have examined the effect of various durations of neonatal hyperoxia 
(most commonly continuing through the first 4–14 postnatal days) on alveolar lung 
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development.11,12,14,33,38–40 However, despite the diagnosis of BPD being based on the 
physiological need for oxygen, previous models have not adequately assessed the 
relationship between alveolar–capillary structure and diffusion function. Moreover, it has 
been common practice to infer loss of alveolar surface area based on an increase in mean 
linear intercept (MLI), a two-dimensional assessment of lung structure, despite calls to 
carefully quantitate distal lung structure by stereology.25 Similar to previous reports,14,41 our 
results demonstrate a stepwise increase in MLI proportionate to cumulative neonatal 
hyperoxia exposure. However, our stereological estimates of alveolar surface area, which 
unlike MLI account for differences in lung volume,25,26 clearly reveal a similar decrease in 
alveolar surface area whether the insult is confined to saccular (P0-4), saccular/early alveolar 
(P0-7), or the entirety of postnatal saccular and bulk alveolar (P0-14) lung development. 
Likewise, estimation of the volume of the alveolar wall (V(aw)) following all three hyperoxia 
exposures was similarly reduced. Despite the significant increase in MLI with chronic 
neonatal hyperoxia exposure through day 14, an increase in lung volume resulted in the 
relative preservation of alveolar surface area and septal wall volume compared to those 
animals exposed to shorter durations of neonatal hyperoxia. Our findings suggest that the 
effects of neonatal hyperoxia on alveolar septal development are significant very early on, 
where even relatively brief exposures (P0-4) are sufficient to significantly reduce the surface 
area for gas exchange. Although our results reinforce the notion that MLI alone may not be 
adequate to describe the structural changes following hyperoxia exposure, we demonstrate 
that MLI did correlate significantly with DFCO. Thus, our data would support the notion that 
MLI may be a reasonable surrogate for functional diffusion. However, it is important to note 
that none of the measures of distal lung development, including MLI, correlated tightly with 
DFCO, suggesting that it is imperative to compliment structural assessment with functional 
measures. Furthermore, given that we only observed loss of pulmonary microvascular 
volume with prolonged hyperoxia (14 days) and that our assessments of pulmonary 
microvascular development were not significantly correlated with DFCO, our data highlights 
the need to more carefully evaluate current methods which assess microvascular 
development in models of BPD, and develop functional methods to more clearly delineate 
the contribution of the microvasculature to functional gas exchange.
The strength of the neonatal hyperoxia model is its consistent ability to inhibit alveolar 
development, and alveolar simplification is a major and consistent finding in human 
BPD.8,42 However, the murine neonatal hyperoxia model does not recapitulate every aspect 
of human BPD. Infants dying of BPD demonstrate significant interstitial thickening and 
inflammation, features that are not consistently present and of varying magnitude in rodent 
hyperoxia models.8,9,43 Thus, the current model, may not account for ongoing inflammation 
and alveolar wall thickening, both of which could impact pulmonary diffusion. While human 
BPD is associated with mechanical ventilation and exposure to supplemental oxygen, the 
liberal use of oxygen and, therefore, the degree of oxidative stress, has been reduced. Thus, 
the degree of hyperoxia used in murine models, as compared to current-era practices, may be 
less clinically relevant. It is important to note that the murine lung, at birth, is designed to 
develop normally in an environment of 21% oxygen, which is hyperoxic relative to the 
hypoxic intrauterine environment in which a human lung at the same stage typically 
develops. Therefore, it is plausible that the neonatal mouse may require much higher degrees 
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of hyperoxia to recapitulate the same degree of oxidative stress. We utilized >90% oxygen as 
this is the level at which we have documented that despite recovery, alveolar structural and 
functional changes persist.6,21 Furthermore, the resulting alveolar simplification with 
minimal-to-mild fibrosis is similar to the histopathological changes in the limited autopsy 
samples from children with post-surfactant-era, “new BPD.8” Likewise, the impairments in 
alveolar–capillary function we demonstrate with the current model are similar to those 
reported in longitudinal studies of children and adolescents recovering from modern-era 
BPD.10,28,30 Although not without important caveats, the murine neonatal hyperoxia, 
therefore, continues to be a useful pre-clinical model of the structural and functional 
consequences of clinical BPD today.
The method of using DFco to estimate pulmonary diffusion function may not be as precise 
as the clinically-determined values of DLco due to the relatively small size of the mouse and 
the small volume of test gas that can be delivered. The DFco relies on the ratio of carbon 
monoxide uptake to neon dilution to account for “contamination” with ambient air 
introduced to the sample during the procedure and via anatomical dead space. Therefore, the 
DFco more closely approximates pulmonary diffusion per alveolar volume (DLCO/VA), 
which is conceptually different than DLCO which is an absolute measure of diffusion.19,44 
Given the increase in alveolar volume that we observed with increased duration of neonatal 
hyperoxia, it is important to account for changes in alveolar volumes when comparing CO 
uptake between groups. Increased alveolar volume results in increased dilution of CO and 
potentially provides, in a structurally normal lung, increased surface area for diffusion. 
These important distinctions must be accounted for when attributing differences in DLCO to 
differences in alveolar structure. Clinically, both DLCO and DLCO/VA are reduced in infants 
formerly diagnosed with BPD, suggesting reduced efficiency of diffusion per alveolar 
volume due to decreased surface area and/or reduced capillary volume.5,10,27–30 Despite the 
limitations of DFCO, it provides a simple, cost-effective, and convenient method to assess 
pulmonary diffusion in small animals and lends valuable insight into functional impairment.
In summary, we have demonstrated that, whether limited to the saccular or continued 
throughout saccular and bulk alveolar postnatal lung development, neonatal hyperoxia 
results in similar reductions of alveolar surface area and alveolar septal volume. 
Consequently, exposure to neonatal hyperoxia in the saccular period is sufficient to 
significantly impair functional alveolar–capillary gas diffusion efficiency. However, with 
prolonged, chronic neonatal hyperoxia (perhaps beyond the clinically-relevant period), there 
is significantly increased alveolar and total lung volume. Importantly, morphometric 
estimates of alveolar development and direct assessment of alveolar–capillary function are 
poorly correlated. Clinically, the majority of infants that develop BPD experience the bulk of 
lung injury during saccular and early alveolar lung development, suggesting that neonatal 
hyperoxia models employing exposures beyond the first 4–7 postnatal days may be less 
clinically relevant.
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Fig. 1. 
Impact of neonatal hyperoxia on pulmonary diffusion and alveolar volume. (A) Assessment 
of the diffusion factor for carbon monoxide (DFCO) at 2 months of age in animals 
continuously raised in room air (RA), or initially exposed to neonatal hyperoxia (≥90% O2) 
for the first 4, 7, or 14 days after birth followed by recovery in RA. (B) Assessment of 
alveolar volume by neon gas dilution. Values are expressed as means±SEM. ***P < 0.001 
versus RA, **P < 0.01 versus RA, #P < 0.05 versus O2 P0-4, ###P < 0.001 versus O2 
P0-4, $$$P < 0.001 versus O2 P0-7 by one way ANOVA using Tukey’s multiple comparison 
post-test analysis. Results are representative of three independent experiments. n = 10 (RA), 
10 (O2 P0-P4), 18 (O2 P0-P7), 9 (O2 P0-P14).
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Fig. 2. 
Development of Alveolar surface area following neonatal hyperoxia. (A–D) Representative 
hematoxylin/eosin stained lung sections at 2 months of age in animals continuously raised in 
(A) RA, or initially exposed to neonatal hyperoxia (≥90% O2) from (B) P0-4, (C) P0-7, or 
(D) P0-14, followed by recovery in RA. Assessment of (E) mean linear intercept (MLI), (F) 
left lung volume by water displacement, and (G) alveolar surface area. Original images 
obtained with 20× objective. Scale bar = 50μm. Values are expressed as means±SEM. ***P < 
0.001 versus RA, ###P < 0.001 versus O2 P0-4, $$$P < 0.001 versus O2 P0-7) by one way 
ANOVA using Tukey’s multiple comparison post-test analysis. Results are representative of 
three independent experiments. n = 19 (RA), 10 (O2 P0-P4), 12 (O2 P0-P7), 9 (O2 P0-P14).
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Fig. 3. 
Effect of Neonatal hyperoxia on pulmonary microvascular development. Pulmonary 
microvascular volume was assessed using stereological analysis on von Willebrand-stained 
lung sections to identify vessels 20–50μm in diameter. Values are expressed as means
±SEM. *P < 0.05 versus RA by one way ANOVA using Tukey’s multiple comparison post-
test analysis. Results are representative of three independent experiments. n = 11 (RA), 10 
(O2 P0-P4), 12 (O2 P0-P7), 9 (O2 P0-P14).
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Fig. 4. 
Correlation between estimates of distal lung alveolar–capillary simplification and functional 
impairment. Correlation of mean linear intercept (MLI) (A), volume fraction of the alveolar 
septal wall (B), alveolar surface area (C), pulmonary microvascular volume (D), alveolar 
surface area per lung volume (E), and pulmonary microvascular volume per lung volume (F) 
with DFCO. Analysis performed using simple linear regression.
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